REG - Avon Protection PLC - Annual General Meeting - Trading Update

Avon TechnologiesAnnouncement

28/01/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220128:nRSb9129Za&default-theme=true

RNS Number : 9129Z  Avon Protection PLC  28 January 2022

28 January 2022

Avon Protection plc

Annual General Meeting - Trading Update

In advance of its Annual General Meeting being held at 10.30am today, Avon
Protection provides the following trading update for its financial year ended
30 September 2022.

 

Summary

Trading has continued as expected and in line with the trends described in the
results announcement on 15 December 2021, with organic revenues in the first
quarter ahead of the comparable prior year period. Supply chain disruptions,
as communicated last year, continue but are now largely stable, with
mitigating actions continuing to be taken. The Board therefore remains
confident of achieving its expectations for the current financial year.

 

Customer demand continues to be robust, however given continued longer order
lead times, we expect revenues to be weighted to the second half of the year.
Overheads in the first half of the year are expected to be at a similar run
rate to the second half of our 2021 financial year. Actions to reduce costs in
light of the announced closure of the armor business have commenced, with the
benefits of these first actions reducing the overhead run rate in the second
half.

 

Respiratory protection

We continue to see further progress with the NATO Framework Contract.
Additional orders have been received from the initial six customers, with
Latvia becoming the seventh country to order under the framework and
conversations with other nations with respect to joining the programme
continuing.

 

We are also seeing success with our MCM100 underwater rebreather with an
initial order from Belgium following a competitive tender, bringing the total
number of countries purchasing this product to seven.  The outcome of the
U.S. Navy underwater rebreather tender process is currently expected to be
announced in the second quarter of this financial year.

 

We anticipate follow-on orders under our long-term U.S. DOD contracts during
the first half of the 2022 financial year and have good visibility of a wider
pipeline of opportunities in the U.S. and globally for both military and first
responder customers.

 

Head protection

Delivery of the existing first-generation Integrated Head Protection System
(IHPS) helmet continues and we are well advanced in our preparations to submit
helmets for the first article testing for the next-generation IHPS during the
second quarter of our 2022 financial year.

 

We continue to be pleased with the response from both military and first
responder customers to our F90 mid-range helmet which was launched in the
fourth quarter of our 2021 financial year after being developed in
collaboration between Ceradyne and Team Wendy.  We are actively pursuing a
strong pipeline of opportunities in both the military and first responder
markets for the F90 and Team Wendy EXFIL range of helmets.

 

Closure of the armor business

Following the announcement in December, detailed plans have been developed to
complete the closure of the armor business during our 2023 financial year.
Discussions with customers to finalise their order requirements and plan the
transition to other sources of supply are continuing productively and actions
to reduce the cost base of the business ahead of closure have commenced.
Progress has been made finalising the first article test approvals for the DLA
ESAPI body armor product and we continue to expect the approvals to be
finalised during this second quarter of our 2022 financial year.

 

Share buy back

As separately announced today, following consultation with our shareholders,
we are launching a share buy back of up to £18.5 million ($25 million).  As
previously announced, the Board does not intend to initiate any major merger
and acquisition activity in 2022 and given the strong financial position and
expected cash generation, the purpose of this buy-back is to maximise the
efficiency of the balance sheet for shareholders' benefit.

 

For further enquiries, please contact:

 

 Avon Protection plc
 Paul McDonald, Chief Executive Officer          01225 896 848
 Nick Keveth, Chief Financial Officer
 Rachel Stevens, Director of Investor Relations

 MHP Communications
 Andrew Jaques                                   0203 128 8570
 Charlie Barker                                  avonprotection@mhpc.com (mailto:avonrubber@mhpc.com)
 Pete Lambie

 

Legal Entity Identifier: 213800JM1AN62REBWA71

Certain information contained in this announcement would have constituted
inside information (as defined by Article 7 of Regulation (EU) No 596/2014)
("MAR") prior to its release as part of this announcement and is disclosed in
accordance with the Company's obligations under Article 17 of those
Regulations.

Note to editors:

Avon Protection designs and produces life critical personal protection
solutions for the world's militaries and first responders. With a portfolio
that includes Chemical, Biological, Radiological, Nuclear ("CBRN"),
respiratory and head protection products, Avon Protection's mission is to
relentlessly advance the future of protection enhancing the performance,
efficiency and capability of their customers whilst providing ever increasing
levels of protection.

Avon Protection operates from 7 locations employing more than 1,000 people and
is listed on the London Stock Exchange (LSE: AVON).

For further information, please visit our
website www.avon-protection-plc.com (http://www.avon-protection-plc.com/)
.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTPPUBUGUPPPUM